Project Notice |
|
PNR | 44621 |
Project Name | Polpharma R&D |
Project Detail | Project Description Provision of long-term financing to Zaklady Farmaceutyczne Polpharma S.A. ("borrower", "client") to support the introduction of new technologies and enhancement of in-house R&D competencies, Green Economy Transition (GET)-eligible investments and replacement of temporary bridge financing and short term credit lines with a more permanent finance structure (the "project"). The EBRD will act as a co-lender alongside Polish commercial banks. Project Objectives The operation will support the European pharmaceutical industry during the pandemic and enable the company to increase its global sales presence through the development of value-added products as well as the introduction of new technologies that will facilitate the development of new substances and products to penetrate currently unavailable market niches. The project will also support a Polish pharma blue-chip to maintain its leadership position in Central and Eastern Europe and the Commonwealth of Independent States and streghten its international footprint. |
Funded By | European Bank for Reconstruction and Development (EBRD) |
Sector | Oil & Gas |
Country | Poland , Eastern Europe |
Project Value | Plz Refer Document |
Contact Information |
|
Company Name | ZAKLADY FARMACEUTYCZNE POLPHARMA SA |
Address | Magdalena Rzeszotalska magdalena.rzeszotalska@polpharma.com 00 48 607 696 473 www.polpharma.pl |
Web Site | https://www.ebrd.com/work-with-us/projects/psd/52459.html |